TRCT
PHVS icon

Tower Research Capital (TRC)’s Pharvaris PHVS Stock Holding History

Tower Research Capital (TRC)’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.4K Buy
676
+438
+184% +$13.3K ﹤0.01% 3412
2026
Q1 		$6.72K Sell
238
-233
-49% -$6.22K ﹤0.01% 4041
2025
Q4 		$13.1K Buy
+471
New +$11.3K ﹤0.01% 3430
2023
Q1 		– Sell
-12,993
Closed -$146K – 6178
2022
Q4 		$146K Buy
12,993
+9,533
+276% +$50.1K 0.01% 1535
2022
Q3 		$26K Buy
+3,460
New +$54.1K ﹤0.01% 3723
2022
Q2 		– Sell
-77
Closed -$1K – 6423
2022
Q1 		$1K Buy
+77
New +$1.36K ﹤0.01% 5836
2021
Q4 		– Sell
-211
Closed -$4K – 6461
2021
Q3 		$4K Sell
211
-350
-62% -$5.99K ﹤0.01% 4992
2021
Q2 		$11K Buy
+561
New +$12.7K ﹤0.01% 4334

Other funds holding PHVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Tower Research Capital (TRC)'s PHVS Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Pharvaris (PHVS) stake by 184% in Q2 2026, buying an estimated $13.3K and bringing the position to 676 shares worth $23.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3412.

Tower Research Capital (TRC) first reported a position in PHVS in Q2 2021 and has held it in 8 quarters since. The position peaked at $146K in Q4 2022. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • Tower Research Capital (TRC) held 676 shares of Pharvaris worth $23.4K as of Q2 2026.
  • Tower Research Capital (TRC) bought 438 Pharvaris shares in Q2 2026, an estimated $13.3K.
  • Pharvaris made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3412 holding.
  • Tower Research Capital (TRC) first reported a position in Pharvaris in Q2 2021 and has held it in 8 quarters since.
  • Tower Research Capital (TRC)'s Pharvaris position peaked at $146K in Q4 2022.
  • 125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.